Sign In
Buy ICAD
$3.87
+0 (+0%)
At Close: Oct 16, 2025
The 3 Best Millionaire-Maker Stocks to Buy for April 2023
04:28pm, Friday, 07'th Apr 2023
It's certainly not easy to find millionaire-maker stocks if you only have $50,000 or less to invest. In order to turn that amount of money into $1 million using a single stock, you'll need vision, a c
iCAD, Inc. (ICAD) Q4 2022 Earnings Call Transcript
11:15pm, Tuesday, 28'th Mar 2023
iCAD, Inc. (NASDAQ:ICAD ) Q4 2022 Earnings Conference Call March 29, 2023 4:30 PM ET Company Participants Dana Brown - President, Chief Executive Officer Dan Shea - Interim Chief Financial Officer
Icad (ICAD) Reports Q4 Loss, Misses Revenue Estimates
06:18pm, Tuesday, 28'th Mar 2023
Icad (ICAD) delivered earnings and revenue surprises of -9.09% and 0.63%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
7 Tantalizing Technology Stocks to Buy for Long-Term Growth
03:42pm, Tuesday, 14'th Mar 2023
For the last two years, tech stocks have been weighed down by the Steet's worries about elevated inflation and the Fed's rate hikes in response to high inflation. But in the coming months, inflation i
7 Super Speculative Stocks That Could Make You Very Rich
10:14am, Thursday, 23'rd Feb 2023
Growth stocks are indisputably heating up on Wall Street. In a recent CNBC article, the financial news outlet suggested that “retail investors” are responsible for the surge.
7 Drug Stocks That Will Soar in 2023
06:00am, Thursday, 22'nd Dec 2022
Choosing the best drug stocks to buy can be dicey because drug stocks have disadvantages and advantages. On the negative side, you often have to wait many years for promising drugs to prove themselves
Our 7 Top Nasdaq Stock Picks for 2023
09:00am, Friday, 09'th Dec 2022
On Dec. 5, U.S. stocks were dragged down in part by renewed bearishness on the part of Morgan Stanley (NYSE: MS ) analyst Mike Wilson. However, with the U.S. services sector, the job market, and cons
iCAD, Inc. (ICAD) Q3 2022 Earnings Call Transcript
11:26pm, Thursday, 10'th Nov 2022
iCAD, Inc. (NASDAQ:ICAD ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Linnell Faber - Executive Assistant to Chief Executive Officer Stacey Stevens - President &
iCAD: Another Great Candidate For My 'Bio Boom' Speculative Portfolio
06:23pm, Friday, 04'th Nov 2022
The ongoing market-wide sell-off has been ruthless against small-cap tickers, but the comprehensive selling has uncovered iCAD. The ticker is currently undervalued with an attractive risk-reward. ICAD
iCAD to Report Third Quarter 2022 Financial Results on November 10, 2022
08:40am, Thursday, 27'th Oct 2022
NASHUA, N.H., Oct. 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will
7 Little-Known Stocks With Millionaire-Maker Potential
11:34am, Friday, 14'th Oct 2022
Although, on the surface, everything looks gloomy now for stocks, one point that the bears are forgetting, I would argue, is that we live in an era of unprecedented technological advancement. Never be
After Plunging 29.6% in 4 Weeks, Here's Why the Trend Might Reverse for Icad (ICAD)
11:18am, Friday, 19'th Aug 2022
Icad (ICAD) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates coul
iCAD, Inc. (ICAD) CEO Stacey Stevens on Q2 2022 Results - Earnings Call Transcript
10:17pm, Wednesday, 10'th Aug 2022
iCAD, Inc. (NASDAQ:ICAD ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Tony Takazawa - Director, Investor Relations Stacey Stevens - President and Chief Executive O
Icad (ICAD) Reports Q2 Loss, Lags Revenue Estimates
07:33pm, Wednesday, 10'th Aug 2022
Icad (ICAD) delivered earnings and revenue surprises of 0% and 15.08%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
iCAD to Present at the JMP Securities Life Sciences Conference on June 15-16, 2022
08:08am, Monday, 06'th Jun 2022
NASHUA, N.H., June 06, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company w
